Cidara Therapeutics Inc (CDTX)

03:07 AM

Using Ichimoku Cloud for Cidara Therapeutics Inc. technicals2025 AllTime Highs & Daily Profit Focused Screening - newser.com

03:07 AM

09:15 AM

How Cidara Therapeutics Inc. stock benefits from strong dollarPortfolio Growth Summary & Daily Technical Stock Forecast Reports - newser.com

09:15 AM

03:32 AM

Cidara Therapeutics Inc.’s volatility index tracking explainedWeekly Investment Summary & Real-Time Buy Zone Alerts - newser.com

03:32 AM

Oct 16, 2025

FDA Grants Cidara Therapeutics’ CD388 Breakthrough Therapy Designation for Flu Prevention in High-Risk Patients - Insider Monkey

Oct 16, 2025

Oct 16, 2025

Morgan Stanley Backs Cidara Therapeutics (CDTX) with $190 Price Target - GuruFocus

Oct 16, 2025

Oct 16, 2025

Cidara Therapeutics gains overweight rating at Morgan Stanley - Seeking Alpha

Oct 16, 2025

Oct 16, 2025

Morgan Stanley Initiates Coverage on CDTX with Overweight Rating - GuruFocus

Oct 16, 2025

Oct 16, 2025

Morgan Stanley Initiates Cidara Therapeutics at Overweight With $190 Price Target - MarketScreener

Oct 16, 2025

Oct 15, 2025

Analyzing drawdowns of Cidara Therapeutics Inc. with statistical toolsQuarterly Market Summary & Verified Momentum Watchlists - newser.com

Oct 15, 2025

Oct 15, 2025

Will Cidara Therapeutics Inc. stock deliver long term returnsMarket Growth Report & Safe Capital Growth Trade Ideas - newser.com

Oct 15, 2025

Oct 15, 2025

How risky is Cidara Therapeutics Inc. stock nowPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

How Cidara Therapeutics Inc. stock compares to growth peers2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com

Oct 15, 2025

Oct 14, 2025

Can Cidara Therapeutics Inc. (20D0) stock reach $200 price targetJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com

Oct 14, 2025

Oct 13, 2025

Cidara Therapeutics to Present at 10th ESWI Influenza Conference 2025 - MarketScreener

Oct 13, 2025

Oct 13, 2025

Can machine learning forecast Cidara Therapeutics Inc. recoveryWeekly Trade Report & Verified Stock Trade Ideas - newser.com

Oct 13, 2025

Oct 13, 2025

Cidara to present phase 2 data on influenza drug at ID Week 2025 - Investing.com

Oct 13, 2025

Oct 13, 2025

Cidara Therapeutics to Present Late-Breaking Phase 2 Data on CD388 for Influenza at ID Week 2025 - Quiver Quantitative

Oct 13, 2025

Oct 13, 2025

Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025 - GlobeNewswire

Oct 13, 2025

Oct 13, 2025

Can you recover from losses in Cidara Therapeutics Inc.Weekly Profit Summary & Stepwise Trade Execution Plans - newser.com

Oct 13, 2025

Oct 13, 2025

What hedge fund moves indicate for Cidara Therapeutics Inc. (20D0) stockJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - newser.com

Oct 13, 2025

Oct 12, 2025

What institutional flow reveals about Cidara Therapeutics Inc.Quarterly Trade Report & Verified Momentum Stock Alerts - newser.com

Oct 12, 2025

Oct 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Shares Gap Up on Analyst Upgrade - MarketBeat

Oct 11, 2025

Oct 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Now Covered by JPMorgan Chase & Co. - MarketBeat

Oct 11, 2025

Oct 11, 2025

JP Morgan Initiates Coverage on CDTX with Overweight Rating | CD - GuruFocus

Oct 11, 2025

Oct 10, 2025

Cidara Therapeutics (CDTX) Is Up 10.8% After FDA Grants Breakthrough Therapy Designation to CD388 - Sahm

Oct 10, 2025

Oct 10, 2025

WBB Securities Issues Positive Forecast for Cidara Therapeutics (NASDAQ:CDTX) Stock Price - MarketBeat

Oct 10, 2025

Oct 10, 2025

CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza - sharewise.com

Oct 10, 2025

Oct 10, 2025

Cidara Therapeutics Analyst Says Lead Influenza Candidate Is 'Strategically Attractive' - Benzinga

Oct 10, 2025

Oct 10, 2025

Why Cidara Therapeutics (CDTX) Is Up 12.4% After Breakthrough Therapy Status for Novel Flu Drug CD388 - Yahoo Finance

Oct 10, 2025

Oct 10, 2025

Cidara Therapeutics (NASDAQ:CDTX) Hits New 12-Month High Following Analyst Upgrade - MarketBeat

Oct 10, 2025

Oct 10, 2025

Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $150.00 - MarketBeat

Oct 10, 2025

Oct 10, 2025

Cidara Therapeutics Surges Ahead of ESWI 2025 Presentation and JP Morgan Coverage - Benzinga

Oct 10, 2025

Oct 10, 2025

Cidara Therapeutics stock price target raised to $150 at H.C. Wainwright - Investing.com Canada

Oct 10, 2025

Oct 10, 2025

JP Morgan Initiates Coverage of Cidara Therapeutics (CDTX) with Overweight Recommendation - Nasdaq

Oct 10, 2025

Oct 10, 2025

How to build a dashboard for Cidara Therapeutics Inc. stockWeekly Risk Summary & AI Enhanced Trading Signals - newser.com

Oct 10, 2025

Oct 10, 2025

JPMorgan Initiates Coverage on Cidara Therapeutics With Overweight Rating, $200 Price Target - MarketScreener

Oct 10, 2025

Oct 10, 2025

Forecasting Cidara Therapeutics Inc. price range with options data2025 Volatility Report & Stepwise Swing Trade Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Biotech And Healthcare Stocks Hit 52-Week Highs: Is The Momentum Sustainable? - Nasdaq

Oct 10, 2025

Oct 10, 2025

Why Cidara Therapeutics Inc. stock could be next big winnerQuarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com

Oct 10, 2025

Oct 09, 2025

Cidara Therapeutics' (CDTX) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025